Anti-PD-L1 therapy yielded durable responses in early NSCLC trials

http://www.wset.com/story/24592051/hidden-killer-part-1-why-doctors-are-...

http://healthblog.dallasnews.com/2014/01/how-do-you-know-you-have-hepati...

http://www.usatoday.com/story/news/nation/2014/01/29/hepatitis-c-treatme...

Kansas City Research Institute Introduces Non-Invasive Technology
for Liver Disease Diagnosis

Non-invasive examination replaces costly, painful biopsy procedure

http://goo.gl/MKUJzC

Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients

http://kcur.org/post/kansas-city-doctor-behind-new-breakthrough-hepatitis-c-drug

http://fox4kc.com/2013/12/12/new-weapon-to-cure-hepatitis-c/

KANSAS CITY, Mo. — Hepatitis C is a liver-destroying virus that’s most common in baby boomers. Many got it years ago from IV drug use or unsafe sex. Now there’s a new drug to cure it.

High levels of immune cells in tumors may ID breast cancer pts most likely benefit from trastuzumab